Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Insulin
Insulin is a hormone produced by the pancreas that plays a pivotal role in regulating glucose metabolism in horses. It facilitates the uptake of glucose by cells, thus maintaining blood sugar levels within a normal range. Insulin's function is integral to energy balance and metabolic processes in equines. Disruptions in insulin regulation can lead to metabolic disorders such as Equine Metabolic Syndrome (EMS), characterized by insulin resistance and associated with obesity and laminitis. This page aggregates peer-reviewed research studies and scholarly articles that explore the physiological role, regulatory mechanisms, and clinical implications of insulin in equine health and disease management.
Equine Metabolic Syndrome and Insulin Dysregulation. Equine metabolic syndrome (EMS) is defined as a collection of metabolic and clinical features that contribute to the development of hyperinsulinemia-associated laminitis (HAL). Insulin dysregulation (ID) is the hallmark feature of EMS and a risk factor for development of HAL. There are several diagnostic tests that can be used to diagnose various forms of ID in horses and ponies. Treatment of EMS/ID includes providing an appropriate diet, exercise program, and pharmacologic intervention in some severe cases.
Evaluation of a new immunoassay for measuring equine serum insulin and plasma adrenocorticotrophic hormone: A method comparison study. Insulin dysregulation (ID) and pituitary pars intermedia dysfunction (PPID) are common equine endocrinopathies detected by measurement of circulating insulin and adrenocorticotrophic hormone (ACTH) concentrations. Different assays may yield variable results, limiting comparability. Objective: To compare immunoassays developed specifically to measure equine insulin (VIDAS® Equine Insulin; enzyme-linked fluorescent assay [ELFA]) and equine ACTH (VIDAS® Equine ACTH; ELFA) with results obtained from a chemiluminescence immunoassay (CLIA) measured using IMMULITE 2000XPi, a chemiluminescence enzym...
Blood pressure, electrolyte and fluid balance in horses with insulin dysregulation after short-term treatment with canagliflozin. Short-term treatment with SGLT-2 inhibitors decreases blood pressure in people with type 2 diabetes. The aim was to investigate the impact of a 3-week treatment with canagliflozin on blood pressure in insulin dysregulated (ID) horses and to study effects on fluid balance. This was a single-centre, randomised, double-blind, placebo-controlled, parallel design study. The primary study evaluated glucose and insulin responses during an oral sugar test, and these results have been published previously. Here we report the effect of canagliflozin treatment on blood pressure, PCV, serum proteins and e...
Pituitary Pars Intermedia Dysfunction. Pituitary pars intermedia dysfunction (PPID) is one of the most common equine endocrine disorders. It is caused by oxidative damage to dopaminergic neurons in the hypothalamus and results in loss of inhibition of the pituitary pars intermedia. This leads to increased circulating concentrations of adrenocorticotropic hormone (ACTH) and related peptides. Diagnosis is based on increased resting and/or thyrotropin releasing hormone-stimulated ACTH concentrations. Assessment of insulin regulation is also important, as insulin dysregulation occurs in at least one-third of PPID cases and is associate...
High molecular weight adiponectin as an adjunct biomarker for insulin dysregulation in equids. Total adiponectin concentration is associated with hyperinsulinemia and laminitis risk in ponies but the high molecular weight (HMW) multimer is a more sensitive indicator of metabolic disease in other species and could be a useful biomarker for insulin dysregulation (ID). Objective: To determine a cut-off value for using HMW adiponectin as an adjunct diagnostic tool for ID. Methods: Cohort of 127 privately and university-owned horses and ponies of various breeds with 55 classified as ID positive and 72 as ID negative. Methods: Cohort study. Baseline and postprandial blood samples from an in-f...
Body Condition, Metabolic Parameters and Semen Traits in Purebred Spanish Horses. The growing relevance of the Purebred Spanish horse has driven the extensive use of assisted reproductive technologies to preserve elite stallion genetics. Optimal reproductive performance is intrinsically linked to systemic health and high semen quality. This study aimed to evaluate the impact of body condition on the stallion's metabolic and endocrine profiles and their seminal parameters. Semen and blood samples were collected from 26 stallions (February-May in 2024-2025) whose body condition score (BCS) was assessed using the Henneke scale. They were classified into two groups, low BCS wit...
Hypothalamic-pituitary-adrenal axis response and glucose homeostasis during exercise to fatigue before and after training in old and young adult Standardbred mares. While reduced cortisol responses to exercise have been described in older horses, the effects of aging and training on the hypothalamic-pituitary-adrenal axis (HPA axis) and downstream metabolic signaling are currently unknown. Unassigned: This study tested the hypothesis that age and exercise training alter the response of the HPA axis, insulin, and glucose during an acute exercise challenge to fatigue. Methods: Six old (22.0±0.7 years) and six young adult (7.3±0.6 years) unfit Standardbred mares were tested. Mares ran a graded exercise test before (GXT1) and after (GXT2) 8 weeks of trainin...
Canagliflozin treatment of a horse with hyperinsulinemia, including pharmacokinetic analysis of different dosing protocols: a case report. Laminitis is a complex and painful disease of the equine foot. Insulin dysregulation (ID) resulting in hyperinsulinemia is responsible for more than 90% of cases in the general horse and pony population. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a relatively new class of drug that has gained considerable popularity as an off-label treatment of hyperinsulinemia-associated laminitis (HAL) in horses when traditional management changes and treatments are unsuccessful. In Canada, canagliflozin is the SGLT2i most available to equine veterinarians; although no dosing protocols have been ...
Circulating microRNAs as potential predictive biomarkers of equine metabolic syndrome. Equine Metabolic Syndrome (EMS) is a complex endocrine disorder characterized by insulin dysregulation (ID), and an increased risk of developing laminitis, often accompanied by generalized or regional adiposity. Despite growing awareness of EMS, early and accurate diagnosis remains challenging. In this pilot study, we investigated changes in the levels of circulating microRNAs (miRNAs) in plasma samples from horses diagnosed with EMS (n=13), compared to overweight/obese (OW/OB) non-ID horses (n=16) and healthy controls (n=16). Using a targeted OpenArray, followed by a Kruskal-Wallis and Dunn's...
Sixty minutes of daily solitary turnout improved physiological and behavioral indicators of stress and welfare in stall-housed horses. Housing horses in stalls restricts natural roaming behaviors, which in turn increases stress and stereotypic behaviors. Daily turnout for voluntary exercise is common for stress mitigation, but there is no consensus for optimal duration of turnout sessions. Objective: We sought to understand how minimal and moderate-duration daily turnout affects behavioral and physiological stress indicators. Methods: In a Latin-square design, adult Quarter horses (N=11) were allowed 0, 15, or 60 minutes/day of solitary turnout for 12-day periods. In-stall behaviors and 24-hour time budgets were assessed on d...
Prevalence of insulin dysregulation in a sport horse population as determined by traditional and stall-side testing. The prevalence of insulin dysregulation (ID) has not been investigated in sport horses. Stall-side insulin assays offer convenience but need further validation. Objective: To determine the prevalence of and risk factors for ID in a sport horse population using an oral sugar test (OST) and assess agreement between stall-side and validated laboratory assays for insulin quantification. Methods: Prospective cross-sectional study. Methods: One hundred eighty sport horses presenting for orthopaedic evaluation at a university hospital (N = 140) or local farms (N = 40) were tested for ID using...
Efficacy and safety of canagliflozin in insulin dysregulated horses: a 4-week multi-arm, double-blind, randomized, clinical trial. Sodium-glucose cotransporter-2 (SGLT2) inhibitors are promising drugs for treatment of hyperinsulinemia in insulin-dysregulated (ID) horses. Objective: Compare short-term effects of the SGLT2 inhibitor canagliflozin versus placebo on glucose and insulin responses during an oral sugar test (OST) and a forage-based feed challenge test (FCT), and to assess adverse effects. Methods: Forty-two privately owned severely ID horses. Methods: Multi-center, randomized, double-blind, placebo-controlled, parallel-group study. Horses were allocated (1:1:1) to receive canagliflozin (0.6 or 1.2 mg/kg PO q24h...
Serum adipokines are useful for predicting hyperinsulinemia secondary to corticosteroid treatment in horses. To evaluate pretreatment biomarkers for predicting the severity of corticosteroid-induced hyperinsulinemia. Unassigned: Oral glucose tests were performed before (day 1) and after (day 8) a dexamethasone course (0.08 mg/kg, q 48 h) in 24 healthy adult Standardbreds. Associations between day 8 oral glucose test insulin parameters (baseline [T0insulin], maximal [Cmaxinsulin], and area under the curve [AUCinsulin]) and day 1 serum markers (insulin, glucose, adiponectin, leptin, and their ratios) were examined using Spearman correlation, log-linked generalized linear models. Relative risk of exceed...
The Role of Omega-3 Fatty Acids in Horses’ Nutrition-A Review. This narrative review presents examples of omega-3 fatty acids supplementation in horse nutrition. Fats are essential in equine nutrition, serving not only as an energy source but also as functional components influencing health. Among them, omega-3 polyunsaturated fatty acids (PUFAs), particularly EPA and DHA, play a key role in modulating inflammatory and metabolic processes. This review summarizes their effects on respiratory health, equine metabolic syndrome (EMS), musculoskeletal function, reproduction, and early development. Omega-3 supplementation has been shown to support airway inflam...
Metabolic effects and pharmacokinetics of oral cannabidiol (CBD) in Connemara ponies following 21 days of treatment. Cannabidiol (CBD) has gained interest in equine medicine due to its potential therapeutic effects. Preclinical studies suggest that CBD may influence metabolic pathways relevant to metabolic syndrome, which present in both human and equine populations. The aim of this study was to evaluate the effects of oral CBD on metabolic parameters in Connemara ponies and to characterize its pharmacokinetics. Unassigned: A total of 13 Connemara ponies [seven with equine metabolic syndrome (EMS)] were stratified by EMS status and age and randomly assigned to a CBD-treated group (2 mg/kg orally, twice dai...
Short-term clinical responses in horses and ponies treated with canagliflozin: A clinical field study. Treatment with the sodium-glucose co-transporter 2 (SGLT2) inhibitor canagliflozin in insulin dysregulated (ID) horses has shown promising results in randomised clinical trials. Larger field studies are needed to further evaluate treatment responses and potential adverse effects under real-world conditions. Objective: To assess the short-term effects of canagliflozin on postprandial glucose and insulin responses in client-owned horses and ponies with ID using a single-sample feed-challenge test (FCT), and to characterise treatment-associated changes in bodyweight, liver enzyme activities, and ...
Bexagliflozin controls hyperinsulinemia in horses with naturally occurring insulin dysregulation: a placebo-controlled crossover trial. To evaluate bexagliflozin for insulin control in horses with naturally occurring insulin dysregulation. Unassigned: In a randomized, placebo-controlled crossover study, 10 client-owned Arabian horses with hyperinsulinemia (> 30 μIU/mL) were treated with bexagliflozin (0.03 mg/kg, PO, q 24 h; BEXA03) or placebo control for a 10-day treatment period, crossing over after a 4-day washout. After a further 12-day washout, 8 of the horses were treated with bexagliflozin (0.06 mg/kg, PO, q 24 h; BEXA06) for an additional 7-day treatment period. Oral sugar tests were performed at the beginning of e...
Comparison of in vitro degradation of immunoreactive adrenocorticotropic hormone and insulin in equine blood measured by two immunoassay methods. This study compared the in vitro stability of equine plasma adrenocorticotrophic hormone (ACTH) and serum insulin measured by chemiluminescent assay (CLA; Siemens Immulite 2000XPi) and immunofluorescent assay (IFA; Tosoh AIA-900) after storage at 4°C or room temperature (approximately 21°C) for clinically relevant periods. Fresh equine EDTA blood for ACTH and coagulated blood for insulin were aliquoted and analysed immediately (T0) and after storage. ACTH was assessed at 24, 48 and 72 hours; insulin was assessed at 24 hours, 72 hours and 7 days. Percentage recovery relative to T0 was analyse...
Ertugliflozin decreases the insulin spike in non-insulin dysregulated standardbred horses following intra-articular triamcinolone administration. Horses with equine metabolic syndrome (EMS) are at an increased risk of laminitis following corticosteroid use. Ertugliflozin reduces hyperinsulinemia in horses with EMS, and therefore may be a management option to reduce the insulin spike seen post corticosteroid use. It was hypothesised that oral ertugliflozin, administered before and after intra-articular (IA) triamcinolone acetonide (TA), will significantly lower the insulin response in comparison to placebo. A randomised, blinded, placebo-controlled, crossover design was performed on eight adult standardbred geldings with no history of la...
Integrating clinical and rna-seq findings in a mare with recurrent endocrinopathic laminitis linked to equine metabolic syndrome. Equine metabolic syndrome (EMS) is characterized by insulin dysregulation and obesity, which increase the risk of the development of hyperinsulinemia-induced laminitis (HAL). The present report describes a case of severe endocrinopathic laminitis associated with EMS, refractory to treatment. A 5-year-old mare with recurrent HAL presented transient relief upon a low nonstructural carbohydrate diet and conventional therapy. An SGLT2 inhibitor was introduced to reduce resting insulin levels, and improvement was observed until October 2024, when the most severe episode started. Despite adding perg...
Evaluation of the tolerance and effects of 1-deoxynojirimycin on insulin and glucose dynamics in healthy horses and horses at risk for insulin dysregulation. Insulin dysregulation (ID) is common and diminishes welfare of horses. Current management relies on diet and exercise, with variable responses and limited medical options. Alpha-glucosidase inhibitors (AGIs) might provide adjunctive therapy. Objective: To evaluate the tolerance and effects of Reducose®, a Morus alba leaf extract standardized to 5% 1-deoxynojirimycin (DNJ), in healthy horses and horses at risk of ID. We hypothesized DNJ would be well-tolerated and reduce insulin responses to oral sugar tests (OSTs). Methods: Twenty-seven horses: 6 healthy (Phase I), 5 at risk for ID (Phase II)...
Effects of vatinoxan in horses sedated with detomidine and butorphanol for gastroscopy: a randomized clinical study. The peripheral alpha2-adrenoceptor antagonist vatinoxan attenuated the side effects of alpha2-adrenergic sedatives in experimental studies in horses. This clinical study investigated the effects of vatinoxan in horses sedated for gastroscopy with detomidine and butorphanol. Client-owned horses were randomly allocated to receive one of the following two intravenous treatments: detomidine hydrochloride (HCl) (12μg/kg) + butorphanol tartrate (12μg/kg) (DB; n=11) or DB + vatinoxan HCl (200μg/kg) (DBV; n=11). Borborygmi score and heart rate were recorded by auscultation. Sedation level was evalu...
Temporal variation in incretin and insulin secretion in ponies in association with dietary macronutrients. Equine insulin dysregulation (ID) is a common condition that predisposes to hyperinsulinaemia-associated laminitis. Improved pathophysiological understanding would enable better management of ID and reduce the risk of laminitis. The incretin peptides, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), augment the insulin response to dietary glucose and GLP-1 has been implicated in the pathophysiology of ID. However, their temporal variation in response to a low-energy diet has not been reported. This study determined the variation in GLP-1, GIP and insulin ...
Assessment of baseline adrenocorticotropic hormone and insulin concentrations in healthy horses in Saskatchewan over a 1-year period. Endocrine disorders in horses, such as pituitary pars intermedia dysfunction and equine metabolic syndrome, rely on hormone testing for diagnosis, but seasonal and regional variabilities highlight the need for locally generated data. Objective: To characterize monthly blood concentrations of ACTH and insulin over 1 year in healthy horses in Saskatchewan. A secondary objective was to assess the association between these outcomes and the following factors: sex, age, breed, pregnancy status, level of exercise, body condition score, and cresty neck score. Methods: Sixty-eight clinically healthy, c...
The Effect of Lipemia on Insulin and Adiponectin Measurement in Equine Blood Samples. Lipemia is a common comorbidity in horses with obesity or equine metabolic syndrome, but the impact of lipemia on the measurement of insulin and adiponectin has not been evaluated. Objective: To evaluate endogenous and exogenous lipemic interference with equine insulin and adiponectin measurements via several commercial assays. Methods: Endogenous lipemia was evaluated using plasma and serum samples with triglyceride concentrations of 1000 mg/dL (n = 6 each). Sample insulin concentrations were determined via fluorescence enzyme immunoassay (FEIA), ELISA, and lateral flow assay (LFA). ...
Blood and fecal metabolic responses of mature horses fed rhizoma peanut hay. Rhizoma peanut (RP, Arachis glabrata Benth) is an alternative legume forage to alfalfa (ALF, Medicago sativa L.) with less non-structural carbohydrates and crude protein. Yet, metabolic responses to consuming RP hay have never been evaluated in horses. Objective: The objective of this study was to investigate the effect of feeding RP 'Florigraze' hay on fecal and blood metabolic variables compared to alfalfa 'Legendary XHD' and bermudagrass (BMG, Cynodon dactylon L. 'Coastal') hays fed to maintenance horses. Methods: Six mature Quarter Horse geldings (596±40 kg) were randomly assigned to one ...
Differential profiles of GH, IGF-1, and fructosamine in follicular fluid and plasma of cyclic mares. Growth hormone (GH) influences follicular development mainly by stimulating insulin-like growth factor 1 (IGF-1), which acts systemically and locally within the ovary. However, the metabolic profile of follicular fluid (FF) in mares, particularly markers such as fructosamine (FRUCT), an indicator of glucose metabolism, remains poorly characterized. This study aimed to evaluate GH, IGF-1, and FRUCT concentrations in plasma and FF and their variation across follicle sizes. Sixty ovaries were collected during the breeding season from 30 clinically normal mares raised for meat production. Blood sa...
Pancreatic islet remodeling in horses with hyperinsulinemia and pituitary dysfunction. The equine pancreas remains understudied, particularly in the context of endocrine disease. This study aimed to characterize regional islet distribution and composition in the normal equine pancreas and investigate how hyperinsulinemia (HI) and pituitary pars intermedia dysfunction (PPID) influence pancreatic islet morphology and hormone expression. In the first experiment, pancreas samples from eight healthy horses were collected and analyzed across three anatomical locations: left lobe, body, and right lobe. The left lobe exhibited a greater relative islet area and perimeter compared to the ...
Treatment with ertugliflozin mitigates the hyperinsulinemic response to intra-articular triamcinolone acetonide. Intra-articular (IA) corticosteroids can cause hyperinsulinemia, which can subsequently increase the risk of laminitis, particularly in horses with insulin dysregulation (ID). Sodium glucose cotransporter 2 inhibitors (SGLT2i), a drug class that is being utilised more commonly in horses with insulin dysregulation, could potentially be used to control post-IA corticosteroid hyperinsulinemia. Objective: To determine whether treatment with the SGLT2i drug ertugliflozin decreases hyperinsulinemia following intra-articular corticosteroid administration in metabolically normal horses. Methods: Prosp...
Case Report: Inhaled salbutamol in the successful treatment of life-threatening acute hyperkalaemia in an anaesthetised horse. Hyperkalaemia is an uncommon complication of general anaesthesia in healthy horses. This case report describes the occurrence of life-threatening acute hyperkalaemia in a 13-year-old, female French Trotter anaesthetised for experimental right and left atrial 3D electro-anatomical mapping. Intra-operative development of hyperkalaemia (7.55 mmol/L) (Ref. 3.00-4.00 mmol/L) with atrial standstill on ECG necessitated transvenous ventricular pacing while initial treatment with insulin and glucose was initiated. Plasma potassium levels continued to increase (8.00 mmol/L) prompting adjunctive tr...
